By investing in weight care, employers can effectively improve employee health while driving a positive ROI. Discover how a comprehensive program can maximize outcomes.
With the obesity rate in the U.S. expected to reach almost 50% by 2030, it is critical for employers to establish an obesity care strategy that improves employee health and maximizes ROI. However, not all weight management programs are the same. To realize benefits for your workforce and the employer requires an evidence-based, comprehensive weight care program that is built by board-certified providers trained in obesity medicine.
Found provides exactly that. By partnering with a program like Found, employers can be confident that they provide access to weight care that will give their employees tailored treatment based on their unique needs. Investing in a personalized program like Found’s can help employers achieve these benefits
Board-certified providers trained in obesity medicine, in partnership with our Chief Medical Officer, Dr. Rekha Kumar, MD, developed Found’s program. Our providers have extensive experience in the field, having worked for the American Board of Obesity Medicine, Stanford University School of Medicine, Weill Cornell Graduate School of Medical Sciences, and more. Our health coaches are certified to ensure members receive the proper lifestyle guidance based on their unique needs.
Since day one, Found has focused on integrated care delivered by highly trained professionals who have experience and knowledge when it comes to medication and behavior change.
While several weight loss programs are available for employers, many rely only on medications like GLP-1s rather than offering a comprehensive medication toolkit. Or they originated as programs that focused on nutrition, behavior change, or exercise alone and then acquired other companies to expand their offerings. These types of programs can lead to disjointed, low-quality care for employees.
At Found, we have a cohesive approach and personalized treatment plans. MetabolicPrint™ is a proprietary metabolic health assessment engine that Found-affiliated clinicians use to help determine a personalized treatment plan, often with medication, to help people lose weight. It helps replicate the process that leading obesity medicine physicians use when treating patients.
By using specific MetabolicPrint profiles paired with one-on-one consultations with patients, Found’s clinicians tailor care and prescribe medicine responsibly. The MetabolicPrint program helps Found-affiliated providers make initial recommendations for treatment and guides personalized care throughout a member’s weight journey.
Having helped over 250,000 members, Found is one of the largest telehealth weight loss clinics in the U.S., with demonstrated scalability for organizations of any size. Our clinical expertise has empowered our members to achieve sustainable weight loss and find on-scale and off-scale victories, in a way that allows them to feel supported. For employers, an investment in employee health with Found yields benefits in terms of better retention rates and lower health care costs.
Found is among the largest medically supported telehealth weight care clinics in the country, having served more than 250,000 members to date. Our mission is to help employers build happier, healthier teams by effectively improving employee health through comprehensive, personalized weight care.
Ward, Z. J., Bleich, S. N., Cradock, A. L., Barrett, J. L., Giles, C. M., Flax, C., Long, M. W., & Gortmaker, S. L. (2019). Projected U.S. State-Level prevalence of adult obesity and severe obesity. New England Journal of Medicine/the New England Journal of Medicine, 381(25), 2440–2450. https://doi.org/10.1056/nejmsa190930
Navigating the different weight care options available to employers can be challenging. Uncover critical insights to consider when choosing a solution for your team.
Looking to implement a weight loss program for your employees? Gain critical insights to consider when selecting a solution for your team.
Weight care doesn’t have to rely on GLP-1s. Lower-cost non-GLP-1 medications are also clinically effective at driving sustainable health outcomes.
